BCM
CNMD icon

Bayesian Capital Management’s CONMED CNMD Stock Holding History

Bayesian Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,779
Closed -$405K – 574
2025
Q2 		$405K Buy
+7,779
New +$427K 0.06% 330
2024
Q2 		– Sell
-6,104
Closed -$489K – 797
2024
Q1 		$489K Buy
+6,104
New +$544K 0.05% 442
2023
Q4 		– Sell
-6,021
Closed -$607K – 794
2023
Q3 		$607K Buy
+6,021
New +$692K 0.07% 332
2023
Q1 		– Sell
-5,349
Closed -$474K – 833
2022
Q4 		$474K Sell
5,349
-2,400
-31% -$199K 0.07% 371
2022
Q3 		$621K Buy
+7,749
New +$731K 0.13% 233
2020
Q4 		– Sell
-5,386
Closed -$424K – 482
2020
Q3 		$424K Sell
5,386
-3,496
-39% -$285K 0.1% 263
2020
Q2 		$639K Buy
8,882
+180
+2% +$12.5K 0.14% 204
2020
Q1 		$498K Buy
8,702
+5,200
+148% +$480K 0.11% 296
2019
Q4 		$392K Buy
+3,502
New +$373K 0.07% 360
2018
Q4 		– Sell
-3,699
Closed -$293K – 632
2018
Q3 		$293K Sell
3,699
-500
-12% -$38.7K 0.05% 466
2018
Q2 		$307K Buy
+4,199
New +$286K 0.07% 389
2017
Q1 		– Sell
-6,200
Closed -$274K – 446
2016
Q4 		$274K Buy
+6,200
New +$263K 0.07% 448
2016
Q2 		– Sell
-6,000
Closed -$252K – 415
2016
Q1 		$252K Buy
+6,000
New +$235K 0.24% 213

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bayesian Capital Management's CNMD Position: Q3 2025 in Review

Bayesian Capital Management sold out of CONMED (CNMD) in Q3 2025, closing a stake of 7,779 shares — an estimated $405K sold.

Bayesian Capital Management first reported a position in CNMD in Q1 2016 and held it in 13 quarters. The position peaked at $639K in Q2 2020. 273 funds tracked by Wall St. Rank hold CNMD as of Q3 2025.

  • Bayesian Capital Management reported no remaining CONMED position as of Q3 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 7,779 CONMED shares in Q3 2025, an estimated $405K.
  • Bayesian Capital Management first reported a position in CONMED in Q1 2016 and held it in 13 quarters.
  • Bayesian Capital Management's CONMED position peaked at $639K in Q2 2020.
  • 273 funds tracked by Wall St. Rank held CONMED as of Q3 2025.

Based on Bayesian Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.